BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32890606)

  • 1. Potential and pitfalls of 1.5T MRI imaging for target volume definition in ocular proton therapy.
    Via R; Hennings F; Pica A; Fattori G; Beer J; Peroni M; Baroni G; Lomax A; Weber DC; Hrbacek J
    Radiother Oncol; 2021 Jan; 154():53-59. PubMed ID: 32890606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques.
    Daftari Ik; Aghaian E; O'Brien JM; Dillon W; Phillips TL
    Med Phys; 2005 Nov; 32(11):3355-62. PubMed ID: 16372413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy.
    Via R; Pica A; Antonioli L; Paganelli C; Fattori G; Spaccapaniccia C; Lomax A; Weber DC; Schalenbourg A; Baroni G; Hrbacek J
    Radiother Oncol; 2022 Sep; 174():16-22. PubMed ID: 35788353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
    Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
    Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.
    Daftari I; Barash D; Lin S; O'Brien J
    Phys Med Biol; 2001 Feb; 46(2):579-90. PubMed ID: 11229735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning.
    Daftari IK; Mishra KK; O'Brien JM; Tsai T; Park SS; Sheen M; Phillips TL
    Med Phys; 2010 Oct; 37(10):5199-207. PubMed ID: 21089753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
    Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
    Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
    Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning.
    Beenakker JW; Ferreira TA; Soemarwoto KP; Genders SW; Teeuwisse WM; Webb AG; Luyten GP
    MAGMA; 2016 Jun; 29(3):571-7. PubMed ID: 26915081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Magnetic Resonance Imaging-Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma.
    Jaarsma-Coes MG; Ferreira TA; Marinkovic M; Vu THK; van Vught L; van Haren GR; Rodrigues MF; Klaver YLB; Verbist BM; Luyten GPM; Rasch CRN; Beenakker JM
    Ophthalmol Retina; 2023 Feb; 7(2):178-188. PubMed ID: 35840053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy.
    Fleury E; Trnková P; Erdal E; Hassan M; Stoel B; Jaarma-Coes M; Luyten G; Herault J; Webb A; Beenakker JW; Pignol JP; Hoogeman M
    Med Phys; 2021 Mar; 48(3):1315-1326. PubMed ID: 33336379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can CT imaging improve targeting accuracy in clip-based proton therapy of ocular melanoma?
    Slopsema RL; Mamalui M; Bolling J; Flampouri S; Yeung D; Li Z; Rutenberg MS; Dagan R
    Phys Med Biol; 2019 Jan; 64(3):035010. PubMed ID: 30566923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
    Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance safety and compatibility of tantalum markers used in proton beam therapy for intraocular tumors: A 7.0 Tesla study.
    Oberacker E; Paul K; Huelnhagen T; Oezerdem C; Winter L; Pohlmann A; Boehmert L; Stachs O; Heufelder J; Weber A; Rehak M; Seibel I; Niendorf T
    Magn Reson Med; 2017 Oct; 78(4):1533-1546. PubMed ID: 27851881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy.
    Zoberi JE; Garcia-Ramirez J; Hedrick S; Rodriguez V; Bertelsman CG; Mackey S; Hu Y; Gach HM; Rao PK; Grigsby PW
    Brachytherapy; 2018; 17(1):31-39. PubMed ID: 28818442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.
    Guarnaschelli JN; Vagal AS; McKenzie JT; McPherson CM; Warnick RE; Batra V; Breneman JC; Lamba MA
    Pract Radiat Oncol; 2014; 4(5):e195-e201. PubMed ID: 25194105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Anatomic Eye Model From T1-Weighted Volume Interpolated Gradient Echo Magnetic Resonance Imaging of Patients With Uveal Melanoma.
    Nguyen HG; Sznitman R; Maeder P; Schalenbourg A; Peroni M; Hrbacek J; Weber DC; Pica A; Bach Cuadra M
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):813-820. PubMed ID: 29970318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive eye localization in ocular proton therapy through optical eye tracking: A proof of concept.
    Via R; Hennings F; Fattori G; Fassi A; Pica A; Lomax A; Weber DC; Baroni G; Hrbacek J
    Med Phys; 2018 May; 45(5):2186-2194. PubMed ID: 29493800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic irradiation on linear accelerator - ultrasound versus MRI in choroidal melanoma volume calculation.
    Furdova A; Furda R; Sramka M; Chorvath M; Rybar J; Vesely P; Valaskova J; Siska V
    BMC Ophthalmol; 2022 Aug; 22(1):333. PubMed ID: 35931996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative localization of tantalum markers for proton beam radiation of choroidal melanoma by an opto-electronic navigation system: a novel technique.
    Amstutz CA; Bechrakis NE; Foerster MH; Heufelder J; Kowal JH
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1361-6. PubMed ID: 21665382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.